100 related articles for article (PubMed ID: 2711930)
1. Effect of PAF acether on oriented egg phosphatidylcholine multibilayers; interaction with cholesterol; comparison to lyso-PC and lyso-PAF.
Oliver JL; Chachaty C; Wolf C; Bereziat G
Agents Actions; 1989 Jan; 26(1-2):121-2. PubMed ID: 2711930
[No Abstract] [Full Text] [Related]
2. Effects of platelet-activating factor (PAF), lyso-PAF and lysophosphatidylcholine on phosphatidylcholine bilayers, an ESR, 31P-NMR and X-ray diffraction study.
Olivier JL; Chachaty C; Quinn PJ; Wolf C
J Lipid Mediat; 1991; 3(3):311-32. PubMed ID: 1663404
[TBL] [Abstract][Full Text] [Related]
3. Influence of PAF-acether on lecithin-oriented multibilayers monitored by ESR: interaction of PAF-acether with cholesterol.
Olivier JL; Chachaty C; Wolf C; Bereziat G
Biochimie; 1989 Jan; 71(1):105-9. PubMed ID: 2541796
[TBL] [Abstract][Full Text] [Related]
4. MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities.
Baker RR; Chang H
Biochim Biophys Acta; 1998 Jun; 1392(2-3):351-60. PubMed ID: 9630721
[TBL] [Abstract][Full Text] [Related]
5. Effect of platelet-activating factor, lyso-platelet-activating factor, and lysophosphatidylcholine on sperm motion: importance of albumin for motility stimulation.
Jarvi K; Roberts KD; Langlais J; Gagnon C
Fertil Steril; 1993 Jun; 59(6):1266-75. PubMed ID: 8495776
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor (PAF-acether), an activator of neutrophil functions.
Jouvin-Marche E; Poitevin B; Benveniste J
Agents Actions; 1982 Dec; 12(5-6):716-20. PubMed ID: 6299078
[TBL] [Abstract][Full Text] [Related]
8. Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids.
Polonsky J; Tencé M; Varenne P; Das BC; Lunel J; Benveniste J
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7019-23. PubMed ID: 6938950
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol as a factor regulating the influence of natural (PAF and lysoPAF) vs synthetic (ED) ether lipids on model lipid membranes.
Flasiński M; Wydro P; Hąc-Wydro K; Dynarowicz-Łątka P
Biochim Biophys Acta; 2013 Nov; 1828(11):2700-8. PubMed ID: 23906729
[TBL] [Abstract][Full Text] [Related]
10. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
Subramanian VS; Goyal J; Miwa M; Sugatami J; Akiyama M; Liu M; Subbaiah PV
Biochim Biophys Acta; 1999 Jul; 1439(1):95-109. PubMed ID: 10395969
[TBL] [Abstract][Full Text] [Related]
11. Modulation of gut wall paf-acether and precursors by intestinal microflora.
Denizot Y; Raibaud P; Ducluzeau R; Ladiré M; Thomas Y; Benveniste J
Res Immunol; 1990; 141(3):235-40. PubMed ID: 2218055
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.
Benveniste J; Chignard M; Le Couedic JP; Vargaftig BB
Thromb Res; 1982 Mar; 25(5):375-85. PubMed ID: 6803388
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding.
Lartigue-Mattei C; Godeneche D; Chabard JL; Petit J; Berger JA
Agents Actions; 1984 Dec; 15(5-6):643-8. PubMed ID: 6532184
[TBL] [Abstract][Full Text] [Related]
14. Substrate specificities of neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor: differences in the use of 1-alkyl and 1-acyl lysophospholipid acceptors.
Roy Baker R; Chang H
Biochim Biophys Acta; 1998 Feb; 1390(2):215-24. PubMed ID: 9507140
[TBL] [Abstract][Full Text] [Related]
15. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs.
Fitzgerald MF; Moncada S; Parente L
Br J Pharmacol; 1986 May; 88(1):149-53. PubMed ID: 3708213
[TBL] [Abstract][Full Text] [Related]
16. Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins.
Benveniste J; Nunez D; Duriez P; Korth R; Bidault J; Fruchart JC
FEBS Lett; 1988 Jan; 226(2):371-6. PubMed ID: 3338565
[TBL] [Abstract][Full Text] [Related]
17. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation.
Coëffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J
J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906
[TBL] [Abstract][Full Text] [Related]
18. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids.
Tokumura A; Toujima M; Yoshioka Y; Fukuzawa K
Lipids; 1996 Dec; 31(12):1251-8. PubMed ID: 8972457
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.
Pirotzky E; Ninio E; Bidault J; Pfister A; Benveniste J
Lab Invest; 1984 Nov; 51(5):567-72. PubMed ID: 6492758
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor (PAF-acether) and microcirculation: effect of Lyso-PAF and PAF-antagonists.
Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
Braz J Med Biol Res; 1987; 20(5):595-7. PubMed ID: 3452452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
